A global biopharmaceutical company that engages in the discovery, development and commercialization of novel, synthetic, small molecule compounds to address unmet medical needs.
The best Bull and Bear pitches based on recency and number of recommendations.
Rival biopharmaceutical company wins approval for it's drug while ENCYSIVE's drug will require more work before the FDA will approve it...This will cause the firm more money and possibly cause it to go bankrupt...
Read the most recent pitches from players about ENCY.DL.
Find the members with the highest scoring picks in ENCY.DL.
See what the Wall Street professionals think, according to their public statements and filings.